Memantine Hcl/Donepezil Hcl
Brand name: Namzaric
Rank #362 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$27.2M
Total Cost
46,134
Total Claims
$27.2M
Total Cost
1,859
Prescribers
$589
Cost per Claim
1,583
Beneficiaries
54,815
30-Day Fills
$15K
Avg Cost/Provider
25
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$27.2M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $27.2M total
🔎 Data Overview
Average cost of $17,165 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Memantine Hcl/Donepezil Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Marina Neystat | Neurology | Forest Hills, NY | 323 | $217K |
| 2 | Tatyana Tsipursky | Psychiatry | Brooklyn, NY | 309 | $192K |
| 3 | Garo Pehlevanian | Cardiology | Los Angeles, CA | 222 | $154K |
| 4 | Mario Lopez Esqueda | Nurse Practitioner | Brawley, CA | 229 | $154K |
| 5 | Mary Tran | Family Practice | Garden Grove, CA | 231 | $148K |
| 6 | Rena Khanukayeva | Family Practice | Staten Island, NY | 220 | $137K |
| 7 | Charles Asta | Neurology | Teaneck, NJ | 133 | $136K |
| 8 | Margarita Fuzaylova | Psychiatry | Rego Park, NY | 210 | $129K |
| 9 | Michael Dao | Internal Medicine | Garden Grove, CA | 92 | $128K |
| 10 | Brian Hollensworth | Neurology | Mobile, AL | 103 | $127K |
| 11 | Geoffrey Mire | Family Practice | Lafayette, LA | 449 | $125K |
| 12 | Elvira Kamenetsky | Neurology | Brooklyn, NY | 188 | $124K |
| 13 | Wei Lin | Internal Medicine | New York, NY | 170 | $123K |
| 14 | Karo Isagholian | Internal Medicine | Glendale, CA | 188 | $118K |
| 15 | Mark Azbel | Internal Medicine | Brooklyn, NY | 179 | $118K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 359 | Valsartan/Hydrochlorothiazide (Valsartan-Hydrochlorothiazide) | $27.5M | 510,583 |
| 360 | Ropinirole Hcl (Ropinirole Hcl) | $27.5M | 1,204,903 |
| 361 | Trifluridine/Tipiracil Hcl (Lonsurf) | $27.3M | 2,430 |
| 362 | Memantine Hcl/Donepezil Hcl (Namzaric) | $27.2M | 46,134 |
| 363 | Solifenacin Succinate (Solifenacin Succinate) | $27.1M | 343,174 |
| 364 | Insulin Aspart (Niacinamide) (Fiasp Flextouch) | $27.0M | 24,598 |
| 365 | Lisinopril/Hydrochlorothiazide (Lisinopril-Hydrochlorothiazide) | $26.8M | 2,304,445 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology